Hexagon Nutrition IPO GMP Today and Kostak Price
Hexagon Nutrition IPO Grey Market Premium (GMP) today stands at ₹ 0, indicating cautious or neutral market sentiment ahead of listing. The Kostak rate is currently not available, while the Subject to Sauda price is quoted at currently not available. On 26 May 2026, the IPO GMP recorded a high of ₹0 and a low of ₹0 on 26 May 2026, reflecting a quiet phase in the grey market. You can check the day-wise GMP trend below to track price movement and investor sentiment over time.
Hexagon Nutrition IPO is scheduled to open for subscription on June 5, 2026. The public issue aims to raise around ₹139 Cr. and is offered in a price band of ₹42 to ₹45 per share, with a market lot of 333 shares. Investors are closely watching subscription data and grey market trends ahead of the listing.
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 26 May 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 |
Hexagon Nutrition IPO Dates
| Event | Date |
|---|---|
| Open Date | 05 Jun, 2026 |
| Close Date | 09 Jun, 2026 |
| Allotment Date | 10 Jun, 2026 |
| Refund Date | 11 Jun, 2026 |
| Credit to Demat | 11 Jun, 2026 |
| Listing Date | 12 Jun, 2026 |
Hexagon Nutrition IPO Expected Listing Price
| Basis | Value |
|---|---|
| Issue Price (Upper Band) | ₹45 |
| Current GMP | ₹ 0 |
| GMP-Based Listing Estimate | Not yet available |
| Listing Date | 12 Jun, 2026 |
Disclaimer: The listing price estimate above is based purely on the current grey market premium (GMP) and is not a guaranteed prediction. GMP is an unofficial, unregulated indicator and can change significantly in the 24–48 hours before listing. Do not make investment decisions based solely on GMP.
Is Hexagon Nutrition IPO GMP Reliable?
Grey market premium for Hexagon Nutrition IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Hexagon Nutrition IPO full review for a fundamentals-based assessment before making any grey market trades.
Hexagon Nutrition IPO IPO Kostak Rate Explained
The Kostak rate for Hexagon Nutrition IPO is currently not active. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price has not been quoted yet. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Hexagon Nutrition IPO
The company offers a wide range of products including micronutrient premixes, vitamin and mineral blends, protein supplements, ready-to-use therapeutic foods, and clinical nutrition products. Hexagon Nutrition follows a diversified business model catering to both B2B and B2C segments, supplying nutritional ingredients to food and pharmaceutical companies while also selling branded healthcare products. Its strong research and development capabilities, export network across multiple countries, and focus on affordable nutrition solutions have helped the company expand its market presence globally.
Strengths & Risks
Strengths
- ✓ Strong presence in clinical nutrition and micronutrient premix segment.
- ✓ Exports products to over 70 countries across global markets.
- ✓ Diversified product portfolio reduces dependence on single category revenue.
- ✓ Experienced promoter family with long operational industry expertise.
- ✓ Focus on research-driven and affordable nutrition healthcare solutions.
Risks
- ⚠ Raw material price fluctuations may impact operating profit margins.
- ⚠ High competition from established domestic and multinational nutrition companies.
- ⚠ Business depends heavily on regulatory approvals and compliance standards.
- ⚠ Export revenue exposure creates foreign currency fluctuation risks.
- ⚠ Dependence on healthcare and nutrition demand trends for growth.
Frequently Asked Questions about Hexagon Nutrition IPO
What is the GMP of Hexagon Nutrition IPO?
The current Grey Market Premium (GMP) of Hexagon Nutrition IPO is not yet started or active in the market.
What is the Kostak Price of Hexagon Nutrition IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Hexagon Nutrition IPO is : Retail: ₹ 0, SHNI: ₹ 0, BHNI: ₹ 0.
What is the Subject to Sauda Price of Hexagon Nutrition IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is : Retail: ₹ 0, SHNI: ₹ 0, BHNI: ₹ 0.
What is the expected listing price of Hexagon Nutrition IPO based on GMP?
The listing price estimate is not yet available as GMP has not been established for Hexagon Nutrition IPO. Check back closer to the subscription date.
Is the GMP of Hexagon Nutrition IPO increasing or decreasing?
The GMP of Hexagon Nutrition IPO is currently stable. Track the day-wise GMP table above for the latest movement.
Explore Hexagon Nutrition IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!